Lilly Sees Value In Biotech R&D, Will Focus On Partnerships Over Acquisitions
Executive Summary
Lilly is placing more emphasis on implementing its strategic partnerships than completing acquisitions, CEO Sidney Taurel said at a conference sponsored by The Economist in Philadelphia Nov. 19